Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1999 Sep;52(9):665–669. doi: 10.1136/jcp.52.9.665

Cell proliferation in the post-surgical stomach, dietary salt, and the effect of H pylori eradication.

P Willis 1, D A Lynch 1, R Prescott 1, S Lamonby 1
PMCID: PMC501541  PMID: 10655987

Abstract

AIMS: To study the epithelial kinetics of the post-surgical stomach with reference to dietary salt intake and H pylori. METHODS: Endoscopic biopsies of the antrum/anastomosis and corpus were taken for histology and MIB-1 immunostaining. The labelling index (LI%) was determined in the three zones of the gastric glands (zone 1 = surface + gastric pit; zone 2 = isthmus; zone 3 = gland base) in patients with vagotomy and pyloroplasty (n = 12), gastroenterostomy + vagotomy (n = 4), partial gastrectomy (n = 3), and Billroth I operation (n = 3). Dietary salt was determined by urinary sodium/creatinine ratio. Twelve patients were H pylori positive (10 vagotomy and pyloroplasty; 2 partial gastrectomy) and had a repeat biopsy three months after antihelicobacter treatment (10 were H pylori negative after treatment). RESULTS: There was no correlation between salt intake and antrum/anastomosis (r = -0.34; p = 0.2) or corpus (r = -0.16; p = 0.2) labelling indices. Gastric mucosal proliferation is increased in the antrum/ anastomosis compared to the corpus in H pylori positive (p = 0.014) but not H pylori negative subjects (p = 0.084). This may reflect the different types of post-surgical stomach in each group. Gastric mucosal proliferation is reduced in antrum/anastomosis (p = 0.002) and corpus (p = 0.016) following H pylori eradication. CONCLUSIONS: Dietary salt does not influence gastric mucosal proliferation in the post-surgical stomach but H pylori may have a role in gastric stump carcinogenesis.

Full text

PDF
665

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ames B. N., Gold L. S. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science. 1990 Aug 31;249(4972):970–971. doi: 10.1126/science.2136249. [DOI] [PubMed] [Google Scholar]
  2. Bechi P., Balzi M., Becciolini A., Amorosi A., Scubla E., Giachè V., Mazzanti R., Tonelli P., Cortesini C. Gastric cell proliferation kinetics and bile reflux after partial gastrectomy. Am J Gastroenterol. 1991 Oct;86(10):1424–1432. [PubMed] [Google Scholar]
  3. Biasco G., Paganelli G. M., Santucci R., Miglioli M., Barbara L. Cell proliferation kinetics as a marker of gastric cancer risk. Ital J Gastroenterol. 1991 Jan;23(1):24–28. [PubMed] [Google Scholar]
  4. Brenes F., Ruiz B., Correa P., Hunter F., Rhamakrishnan T., Fontham E., Shi T. Y. Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol. 1993 Nov;88(11):1870–1875. [PubMed] [Google Scholar]
  5. Cahill R. J., Kilgallen C., Beattie S., Hamilton H., O'Morain C. Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma. Gut. 1996 Feb;38(2):177–181. doi: 10.1136/gut.38.2.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cahill R. J., Xia H., Kilgallen C., Beattie S., Hamilton H., O'Morain C. Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation. Dig Dis Sci. 1995 Aug;40(8):1627–1631. doi: 10.1007/BF02212681. [DOI] [PubMed] [Google Scholar]
  7. Caygill C. P., Knowles R. L., Hall R. Increased risk of cancer mortality after vagotomy for peptic ulcer: a preliminary analysis. Eur J Cancer Prev. 1991 Oct;1(1):35–37. doi: 10.1097/00008469-199110000-00007. [DOI] [PubMed] [Google Scholar]
  8. Clark C. G., Ward M. W., McDonald A. M., Tovey F. I. The incidence of gastric stump cancer. World J Surg. 1983 Mar;7(2):236–240. doi: 10.1007/BF01656150. [DOI] [PubMed] [Google Scholar]
  9. Correa P., Montes G., Cuello C., Haenszel W., Liuzza G., Zarama G., de Marin E., Zavala D. Urinary sodium-to-creatinine ratio as an indicator of gastric cancer risk. Natl Cancer Inst Monogr. 1985 Dec;69:121–123. [PubMed] [Google Scholar]
  10. De Koster E., Buset M., Fernandes E., Deltenre M. Helicobacter pylori: the link with gastric cancer. Eur J Cancer Prev. 1994 May;3(3):247–257. doi: 10.1097/00008469-199403030-00003. [DOI] [PubMed] [Google Scholar]
  11. Dixon M. F., O'Connor H. J., Axon A. T., King R. F., Johnston D. Reflux gastritis: distinct histopathological entity? J Clin Pathol. 1986 May;39(5):524–530. doi: 10.1136/jcp.39.5.524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Forman D., Newell D. G., Fullerton F., Yarnell J. W., Stacey A. R., Wald N., Sitas F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ. 1991 Jun 1;302(6788):1302–1305. doi: 10.1136/bmj.302.6788.1302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fraser A. G., Sim R., Sankey E. A., Dhillon A. P., Pounder R. E. Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation. Aliment Pharmacol Ther. 1994 Apr;8(2):167–173. doi: 10.1111/j.1365-2036.1994.tb00274.x. [DOI] [PubMed] [Google Scholar]
  14. Houghton P. W., Mortensen N. J., Thomas W. E., Cooper M. J., Morgan A. P., Davies E. R. Intragastric bile acids and scintigraphy in the assessment of duodenogastric reflux. Br J Surg. 1986 Apr;73(4):292–294. doi: 10.1002/bjs.1800730415. [DOI] [PubMed] [Google Scholar]
  15. Imai T., Kobayasi S., Rodrigues M. A., de Camargo J. L., Ogawa K., Iwata H., Tatematsu M. Reduction of cell proliferative activities of gastric stump adenomatous hyperplasias after bile reflux diversion in rats. Carcinogenesis. 1993 Sep;14(9):1765–1769. doi: 10.1093/carcin/14.9.1765. [DOI] [PubMed] [Google Scholar]
  16. Kaminishi M., Shimizu N., Shiomoyama S., Yamaguchi H., Ogawa T., Sakai S., Kuramoto S., Oohara T. Etiology of gastric remnant cancer with special reference to the effects of denervation of the gastric mucosa. Cancer. 1995 Mar 15;75(6 Suppl):1490–1496. doi: 10.1002/1097-0142(19950315)75:6+<1490::aid-cncr2820751518>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  17. Key G., Becker M. H., Baron B., Duchrow M., Schlüter C., Flad H. D., Gerdes J. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest. 1993 Jun;68(6):629–636. [PubMed] [Google Scholar]
  18. Langhans P., Heger R. A., Hohenstein J., Schlake W., Bünte H. Operation-sequel carcinoma of the stomach. Experimental studies of surgical techniques with or without resection. World J Surg. 1981 Jul;5(4):595–605. doi: 10.1007/BF01655015. [DOI] [PubMed] [Google Scholar]
  19. Lee A., Fox J., Hazell S. Pathogenicity of Helicobacter pylori: a perspective. Infect Immun. 1993 May;61(5):1601–1610. doi: 10.1128/iai.61.5.1601-1610.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lynch D. A., Clarke A. M., Jackson P., Axon A. T., Dixon M. F., Quirke P. Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens. J Clin Pathol. 1994 Feb;47(2):122–125. doi: 10.1136/jcp.47.2.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lynch D. A., Mapstone N. P., Clarke A. M., Jackson P., Dixon M. F., Quirke P., Axon A. T. Cell proliferation in the gastric corpus in Helicobacter pylori associated gastritis and after gastric resection. Gut. 1995 Mar;36(3):351–353. doi: 10.1136/gut.36.3.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lynch D. A., Mapstone N. P., Clarke A. M., Sobala G. M., Jackson P., Morrison L., Dixon M. F., Quirke P., Axon A. T. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut. 1995 Mar;36(3):346–350. doi: 10.1136/gut.36.3.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mathai E., Arora A., Cafferkey M., Keane C. T., O'Morain C. The effect of bile acids on the growth and adherence of Helicobacter pylori. Aliment Pharmacol Ther. 1991 Dec;5(6):653–658. doi: 10.1111/j.1365-2036.1991.tb00533.x. [DOI] [PubMed] [Google Scholar]
  24. Miwa K., Hattori T., Miyazaki I. Duodenogastric reflux and foregut carcinogenesis. Cancer. 1995 Mar 15;75(6 Suppl):1426–1432. doi: 10.1002/1097-0142(19950315)75:6+<1426::aid-cncr2820751506>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  25. Moayyedi P., Dixon M. F. Any role left for invasive tests? Histology in clinical practice. Gut. 1998 Jul;43 (Suppl 1):S51–S55. doi: 10.1136/gut.43.2008.s51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Northfield T. C., Hall C. N. Carcinoma of the gastric stump: risks and pathogenesis. Gut. 1990 Nov;31(11):1217–1219. doi: 10.1136/gut.31.11.1217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Offerhaus G. J., Rieu P. N., Jansen J. B., Joosten H. J., Lamers C. B. Prospective comparative study of the influence of postoperative bile reflux on gastric mucosal histology and Campylobacter pylori infection. Gut. 1989 Nov;30(11):1552–1557. doi: 10.1136/gut.30.11.1552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Offerhaus G. J., Tersmette A. C., Huibregtse K., van de Stadt J., Tersmette K. W., Stijnen T., Hoedemaeker P. J., Vandenbroucke J. P., Tytgat G. N. Mortality caused by stomach cancer after remote partial gastrectomy for benign conditions: 40 years of follow up of an Amsterdam cohort of 2633 postgastrectomy patients. Gut. 1988 Nov;29(11):1588–1590. doi: 10.1136/gut.29.11.1588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ohyama S., Yonemura Y., Miwa K., Miyazaki I., Sasaki T. Proliferation assay of human gastric remnant by bromodeoxyuridine and flow cytometry. Gastroenterology. 1992 Sep;103(3):789–793. doi: 10.1016/0016-5085(92)90007-l. [DOI] [PubMed] [Google Scholar]
  30. Onda K., Davis R. L., Shibuya M., Wilson C. B., Hoshino T. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer. 1994 Oct 1;74(7):1921–1926. doi: 10.1002/1097-0142(19941001)74:7<1921::aid-cncr2820740716>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  31. Rojas-Campos N., Sigarán M. F., Bravo A. V., Jimenez-Ulate F., Correa P. Salt enhances the mutagenicity of nitrosated black beans. Nutr Cancer. 1990;14(1):1–3. doi: 10.1080/01635589009514072. [DOI] [PubMed] [Google Scholar]
  32. Sano C., Kumashiro R., Saito T., Inokuchi K. Promoting effect of partial gastrectomy on carcinogenesis in the remnant stomach of rats after oral administration of N-methyl-N'-nitro-N-nitrosoguanidine. Oncology. 1984;41(2):124–128. doi: 10.1159/000225806. [DOI] [PubMed] [Google Scholar]
  33. Sobala G. M., O'Connor H. J., Dewar E. P., King R. F., Axon A. T., Dixon M. F. Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol. 1993 Mar;46(3):235–240. doi: 10.1136/jcp.46.3.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Staël von Holstein C., Willén R., Eriksson S. Gastric stump carcinomas in rats--a reliable gastric cancer model? In Vivo. 1990 Jan-Feb;4(1):65–69. [PubMed] [Google Scholar]
  35. Taylor P. R., Mason R. C., Filipe M. I., Vaja S., Hanley D. C., Murphy G. M., Dowling R. H., McColl I. Gastric carcinogenesis in the rat induced by duodenogastric reflux without carcinogens: morphology, mucin histochemistry, polyamine metabolism, and labelling index. Gut. 1991 Dec;32(12):1447–1454. doi: 10.1136/gut.32.12.1447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Viste A., Bjørnestad E., Opheim P., Skarstein A., Thunold J., Hartveit F., Eide G. E., Eide T. J., Søreide O. Risk of carcinoma following gastric operations for benign disease. A historical cohort study of 3470 patients. Lancet. 1986 Aug 30;2(8505):502–505. doi: 10.1016/s0140-6736(86)90368-5. [DOI] [PubMed] [Google Scholar]
  37. Watanabe H., Takahashi T., Okamoto T., Ogundigie P. O., Ito A. Effects of sodium chloride and ethanol on stomach tumorigenesis in ACI rats treated with N-methyl-N'-nitro-N-nitrosoguanidine: a quantitative morphometric approach. Jpn J Cancer Res. 1992 Jun;83(6):588–593. doi: 10.1111/j.1349-7006.1992.tb00130.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wieman T. J., Max M. H., Voyles C. R., Barrows G. H. Diversion of duodenal contents: its effect on the production of experimental gastric cancer. Arch Surg. 1980 Aug;115(8):959–961. doi: 10.1001/archsurg.1980.01380080053010. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES